Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Jun Ho, Yi"'
Autor:
Changhee Park, Ho Sup Lee, Ka-Won Kang, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok-Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung-Soo Yoon, Youngil Koh
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the authors report a single-arm phase II clinical trial of combination of acalabrutinib,
Externí odkaz:
https://doaj.org/article/1be364a2c8774becbc1348fb645041c5
Autor:
Ji Hyun Lee, Jimin Choi, Chang-Ki Min, Sung-Soo Park, Jae-Cheol Jo, Yoo Jin Lee, Jin Seok Kim, Hyeon-Seok Eom, Jongheon Jung, Joon Ho Moon, Hee Jeong Cho, Myung-won Lee, Sung-Soo Yoon, Ja Min Byun, Jae Hoon Lee, Je-Jung Lee, Sung-Hoon Jung, Ho-Jin Shin, Do Young Kim, Jun Ho Yi, Seung-Shin Lee, Young Rok Do, Dok Hyun Yoon, Hyungwoo Cho, Won Sik Lee, Ho Sup Lee, Jieun Uhm, Hyo Jung Kim, Hee Ryeong Jang, Sung-Hyun Kim, Kihyun Kim
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Carfilzomib, lenalidomide, and dexamethasone (KRd) combination therapy improves the survival of patients with relapsed and/or refractory multiple myeloma (RRMM). Nonetheless, evidence on the use of KRd in Asian populations remains scarce. Accordingly
Externí odkaz:
https://doaj.org/article/064da959c7a04a2988554e9f91efe087
Autor:
Seung-Ah Yahng, Ho-Young Yhim, Jae-Yong Kwak, Ho-Jin Shin, Joon Ho Moon, Hyeon-Seok Eom, Ka-Won Kang, Yong Park, Min Kyoung Kim, Se Ryun Lee, Dae Sik Kim, Hyo Jung Kim, Jun Ho Yi, Young Rok Do, Hye Jin Kang, Sungnam Lim, Deok Hwan Yang
Publikováno v:
HemaSphere, Vol 7, p e60026bd (2023)
Externí odkaz:
https://doaj.org/article/c4d9367f5b6c45c48dcb556ad67750e0
Autor:
Jun Ho Yi, Sung-Soo Park, Chang-Ki Min, Hyeon-Seok Eom, Youngil Koh, Ja Min Byun, Sung-Soo Yoon, Jae Hoon Lee, Sung-Hoon Jung, Je-Jung Lee, Sang Eun Yoon, Kihyun Kim
Publikováno v:
HemaSphere, Vol 7, p e2906421 (2023)
Externí odkaz:
https://doaj.org/article/e97e7814e1244da7be5ff3dbaec6fc4e
Autor:
Seok Jin Kim, Jae-Cheol Jo, Dok Hyun Yoon, Deok-Hwan Yang, Sang Eun Yoon, Gyeong-Won Lee, Jee Hyun Kong, Yong Park, Ka-Won Kang, Ho-Sup Lee, Sung Yong Oh, Ho-Jin Shin, Won Sik Lee, Yoon Seok Choi, Seong Hyun Jeong, Min Kyoung Kim, Hye Jin Kang, Jun Ho Yi, Sung-Nam Lim, Ho-Young Yhim, Young Rok Do, Hwan Jung Yun, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, Won Seog Kim
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionUpfront autologous stem cell transplantation (ASCT) has been recommended for patients who are newly diagnosed with peripheral T-cell lymphoma (PTCL), and CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), an anthracycline-
Externí odkaz:
https://doaj.org/article/3ac432a63fad4f94935c09078e6069be
Autor:
Hee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, Yoo Jin Lee, Sang Eun Yoon, Sung-Soo Park, Do Young Kim, Ho-Jin Shin, Yeung-Chul Mun, Jun Ho Yi, Hyo Jung Kim, Da Jung Kim, Ho Sup Lee, Sung Hwa Bae, Chae Moon Hong, Shin Young Jeong, Jung-Joon Min, Sang Kyun Sohn, Chang-Ki Min, Kihyun Kim, Je-Jung Lee, Joon Ho Moon, The Korean Multiple Myeloma Working Party
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-8 (2021)
Abstract In multiple myeloma (MM), a high number of focal lesions (FL) detected using positron emission tomography/computed tomography (PET/CT) was found to be associated with adverse prognosis. To design a new risk stratification system that combine
Externí odkaz:
https://doaj.org/article/0960ae35758a464c82ae284b692a6988
Autor:
Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yong Oh, Hun Mo Ryoo, Hyo Jung Kim, Won Seog Kim
Publikováno v:
Cancer Communications, Vol 41, Iss 3, Pp 275-278 (2021)
Externí odkaz:
https://doaj.org/article/5d08eb39eacb428a89867494569557f4
Autor:
Jun Ho Yi1, Seong Hyun Jeong2, Seok Jin Kim3, Dok Hyun Yoon4, Hye Jin Kang5, Youngil Koh6, Jin Seok Kim7, Won-Sik Lee8, Deok-Hwan Yang9, Young Rok Do10, Min Kyoung Kim11, Kwai Han Yoo12, Yoon Seok Choi2, Whan Jung Yun13, Yong Park14, Jae-Cheol Jo15, Hyeon-Seok Eom16, Jae-Yong Kwak17, Ho-Jin Shin18, Byeong Bae Park19
Publikováno v:
Cancer Research & Treatment. Jan2023, Vol. 55 Issue 1, p325-333. 9p.
Autor:
Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jung Yong Hong, Ho Sup Lee, Sung Yong Oh, Ho-Jin Shin, Jee Hyun Kong, Jun Ho Yi, Kana Sakamoto, Young Hyeh Ko, Jooryung Huh, Seung-Sook Lee, Kengo Takeuchi, Dong-Yeop Shin, Cheolwon Suh, Won Seog Kim
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background The upregulated expression of the JAK/STAT pathway promotes tumor growth in Hodgkin lymphoma (HL) and primary mediastinal large B-cell lymphoma (PMBCL). Based on the hypothesis that JAK2 is a therapeutic target, we performed a pro
Externí odkaz:
https://doaj.org/article/1fe4ef57e11d40c0847b498eee6a2ca5
Autor:
Hyungwoo, Cho, Dok Hyun, Yoon, Dong-Yeop, Shin, Youngil, Koh, Sung-Soo, Yoon, Seok Jin, Kim, Young Rok, Do, Gyeong-Won, Lee, Jae-Yong, Kwak, Yong, Park, Min Kyoung, Kim, Hye Jin, Kang, Jun Ho, Yi, Kwai Han, Yoo, Won Sik, Lee, Byeong Bae, Park, Jae-Cheol, Jo, Hyeon-Seok, Eom, Hyo Jung, Kim, Seong Hyun, Jeong, Young-Woong, Won, Byeong Seok, Sohn, Ji-Hyun, Kwon, Cheolwon, Suh, Won Seog, Kim
Publikováno v:
Cancer Research and Treatment. 55:684-692
Purpose We conducted a nationwide, multicenter, prospective registry study for newly diagnosed patients with peripheral T-cell lymphoma (PTCL) to better define the clinical characteristics, treatment patterns, survival outcomes, and the role of upfro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942358eff3f8327eb0c396541669754d
https://doi.org/10.4143/crt.2022.1434
https://doi.org/10.4143/crt.2022.1434